Filing Flows › Surgery Partners (SGRY) › Capital expenditures
Surgery Partners (SGRY) capital expenditures by quarter
Surgery Partners' capital expenditures were $21.8M in Q2 2026 (second quarter 2026), +36% from Q1 2026. Over the last 7 quarters it ranged from $12.8M (Q4 2025) to $23.4M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $21.8M | +36% | -7% |
| Q1 2026 | $16.0M | +25% | -30% |
| Q4 2025 | $12.8M | -35% | -43% |
| Q3 2025 | $19.8M | -15% | — |
| Q2 2025 | $23.4M | +3% | — |
| Q1 2025 | $22.7M | +2% | — |
| Q4 2024 | $22.3M | — | — |
Q2 2026 at a glance
Surgery Partners, Q2 2026: revenue $849M (+3% year over year), operating margin 12.0%, net earnings $29.7M, operating cash flow $59.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Surgery Partners' capital expenditures?
Surgery Partners' capital expenditures were $21.8M in Q2 2026 (second quarter 2026), +36% from Q1 2026.
How has Surgery Partners' capital expenditures changed?
Over the last 7 quarters it ranged from $12.8M (Q4 2025) to $23.4M (Q2 2025).